Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.

Analogues of the naturally occurring cyclic hydroxamate dealanylalahopcin, which is an inhibitor of procollagen prolyl-4-hydroxylase, were synthesised and shown to be inhibitors of the human hypoxia-inducible factor prolyl hydroxylases.

Manylion Llyfryddiaeth
Prif Awduron:	Schlemminger, I, Mole, D, McNeill, L, Dhanda, A, Hewitson, K, Tian, Y, Ratcliffe, P, Pugh, C, Schofield, C
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2003

Eitemau Tebyg

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
gan: Mole, D, et al.
Cyhoeddwyd: (2003)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
gan: McNeill, L, et al.
Cyhoeddwyd: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
gan: Tuckerman, JR, et al.
Cyhoeddwyd: (2004)

Regulation of HIF: prolyl hydroxylases.
gan: Stolze, I, et al.
Cyhoeddwyd: (2006)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
gan: Chan, M, et al.
Cyhoeddwyd: (2016)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
gan: Yeoh, K, et al.
Cyhoeddwyd: (2013)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
gan: Yeh, TL, et al.
Cyhoeddwyd: (2017)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
gan: Tian, Y, et al.
Cyhoeddwyd: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
gan: Chowdhury, R, et al.
Cyhoeddwyd: (2016)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
gan: Mecinović, J, et al.
Cyhoeddwyd: (2009)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
gan: Hewitson, K, et al.
Cyhoeddwyd: (2007)

Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.
gan: Elkins, J, et al.
Cyhoeddwyd: (2003)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
gan: Holt-Martyn, JP, et al.
Cyhoeddwyd: (2019)

ENANTIOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN
gan: Baldwin, J, et al.
Cyhoeddwyd: (1990)

STEREOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN
gan: Baldwin, J, et al.
Cyhoeddwyd: (1990)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
gan: Cockman, M, et al.
Cyhoeddwyd: (2019)

Inhibition of hypoxia inducible factor (HIF) hydroxylases
gan: Conejo-Garcia, A, et al.
Cyhoeddwyd: (2005)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
gan: Chowdhury, R, et al.
Cyhoeddwyd: (2013)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
gan: Rasheduzzaman Chowdhury, et al.
Cyhoeddwyd: (2016-08-01)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
gan: Masson, N, et al.
Cyhoeddwyd: (2004)

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.
gan: Hewitson, K, et al.
Cyhoeddwyd: (2002)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
gan: Matthew E Cockman, et al.
Cyhoeddwyd: (2019-09-01)

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.
gan: Epstein, A, et al.
Cyhoeddwyd: (2001)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
gan: Willam, C, et al.
Cyhoeddwyd: (2006)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
gan: Masson, N, et al.
Cyhoeddwyd: (2003)

Oxygen sensing by HIF hydroxylases.
gan: Schofield, C, et al.
Cyhoeddwyd: (2004)

Signalling hypoxia by HIF hydroxylases.
gan: Schofield, C, et al.
Cyhoeddwyd: (2005)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
gan: Andrey A. Poloznikov, et al.
Cyhoeddwyd: (2021-01-01)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
gan: Mayer, M, et al.
Cyhoeddwyd: (2018)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
gan: Takahiro Kambara, et al.
Cyhoeddwyd: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
gan: Kiichi Hirota
Cyhoeddwyd: (2021-04-01)

Iron homeostasis and its interaction with prolyl hydroxylases.
gan: Mole, D
Cyhoeddwyd: (2010)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
gan: Singh, A, et al.
Cyhoeddwyd: (2020)

Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate.
gan: McNeill, L, et al.
Cyhoeddwyd: (2005)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
gan: Chen, R, et al.
Cyhoeddwyd: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
gan: Chen, R, et al.
Cyhoeddwyd: (2014)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
gan: Flashman, E, et al.
Cyhoeddwyd: (2010)

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
gan: Astuti, D, et al.
Cyhoeddwyd: (2011)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
gan: Astuti, D, et al.
Cyhoeddwyd: (2010)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
gan: Moritz J. Strowitzki, et al.
Cyhoeddwyd: (2021-04-01)